Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis

G. Merlini, I. Lousada, Y. Ando, A. Dispenzieri, M. A. Gertz, M. Grogan, M. S. Maurer, V. Sanchorawala, A. Wechalekar, G. Palladini, R. L. Comenzo

Research output: Contribution to journalReview articlepeer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis'. Together they form a unique fingerprint.

Medicine & Life Sciences